Physician profile
John Bonner
NPI 1831151216
$3,518.31
in general payments reported to CMS, 2019-2025
17 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,660 · 2020: $301 · 2021: $164 · 2022: $501 · 2023: $174 · 2024: $309 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $892.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $891.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,545.56 | 2019-2025 | Veritas Vision System |
| Rxsight INC | $368.56 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Alcon Vision LLC | $366.39 | 2020-2025 | Centurion, Clareon, Unity |
| Allergan, INC. | $323.86 | 2019-2021 | |
| Ocular Therapeutix, INC. | $138.60 | 2022-2025 | Dextenza |
| Carl Zeiss Meditec USA, INC. | $129.52 | 2022 | |
| Bausch & Lomb Americas INC. | $113.07 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $107.31 | 2019-2021 | |
| Abbvie INC. | $100.26 | 2023-2024 | Lumigan |
| Novartis Pharmaceuticals Corporation | $94.42 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $75.93 | 2019-2021 | |
| Sight Sciences, INC. | $48.66 | 2020-2024 | Omni Surgical System |
| Kala Pharmaceuticals, INC. | $33.75 | 2019 | |
| Dompe US, INC. | $22.41 | 2025 | Oxervate |
| Oyster Point Pharma, INC. | $20.23 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $16.90 | 2019 | |
| Carl Zeiss Meditec Cataract Technology INC. | $12.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Bonner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.